Integra Lifesciences Holdings (IART) Long-Term Debt Repayments (2016)
Historic Long-Term Debt Repayments for Integra Lifesciences Holdings (IART) over the last 4 years, with Q4 2016 value amounting to $183.8 million.
- Integra Lifesciences Holdings' Long-Term Debt Repayments changed N/A to $183.8 million in Q4 2016 from the same period last year, while for Sep 2017 it was $183.8 million, marking a year-over-year increase of 3764661.19%. This contributed to the annual value of $184.3 million for FY2016, which is 721691.15% up from last year.
- According to the latest figures from Q4 2016, Integra Lifesciences Holdings' Long-Term Debt Repayments is $183.8 million.
- In the past 5 years, Integra Lifesciences Holdings' Long-Term Debt Repayments ranged from a high of $183.8 million in Q4 2016 and a low of $122000.0 during Q1 2014
- Over the past 3 years, Integra Lifesciences Holdings' median Long-Term Debt Repayments value was $164000.0 (recorded in 2016), while the average stood at $17.0 million.
- Per our database at Business Quant, Integra Lifesciences Holdings' Long-Term Debt Repayments surged by 159840.0% in 2015 and then plummeted by 9227.51% in 2016.
- Integra Lifesciences Holdings' Long-Term Debt Repayments (Quarter) stood at $235000.0 in 2014, then soared by 803.4% to $2.1 million in 2015, then surged by 8558.78% to $183.8 million in 2016.
- Its Long-Term Debt Repayments stands at $183.8 million for Q4 2016, versus $164000.0 for Q3 2016 and $163000.0 for Q2 2016.